Vistagen Therapeutics, Inc.
VTGNCIK 0001411685 · last filing Jul 2, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
85,348 bought / 0 sold
net +85,348 sh · +$16.4K
- buys
- 3
- sells
- 0
- insiders active
- 3
Filing tape
Filed Thu, Jul 2, 2026
- +36,818 sh · $7.1K
Adler Reid G. — Chief Legal Officer
- Granted36,818Common Stock@ $0.19→ 60,868 held
- +11,712 sh · $2.2K
Tressler Nick B. — Chief Financial Officer
- Granted11,712Common Stock@ $0.19→ 11,712 held
- +36,818 sh · $7.1K
Singh Shawn — President and CEO · Director
- Granted36,818Common Stock@ $0.19→ 54,846 held
Insiders on this tape
- Adler Reid G.Chief Legal Officer
- Tressler Nick B.Chief Financial Officer
- Singh ShawnPresident and CEO · Director
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.